A detailed history of Gamma Investing LLC transactions in Incyte Corp stock. As of the latest transaction made, Gamma Investing LLC holds 5,764 shares of INCY stock, worth $401,347. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,764
Previous 4,874 18.26%
Holding current value
$401,347
Previous $322 Million 23.57%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$65.08 - $83.38 $57,921 - $74,208
890 Added 18.26%
5,764 $398 Million
Q3 2024

Oct 04, 2024

BUY
$57.33 - $68.61 $115,233 - $137,906
2,010 Added 70.18%
4,874 $322 Million
Q2 2024

Jul 02, 2024

BUY
$51.18 - $63.75 $40,483 - $50,426
791 Added 38.16%
2,864 $174 Million
Q1 2024

Apr 05, 2024

BUY
$56.55 - $66.59 $5,089 - $5,993
90 Added 4.54%
2,073 $118 Million
Q4 2023

Feb 01, 2024

BUY
$52.16 - $64.19 $103,433 - $127,288
1,983 New
1,983 $117 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.